The consulting firm The Tauri Group received a potential five-year, $85 million task order as part of an indefinite delivery, indefinite quantity contract to provide advisory and assistance services to the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Directorate. The directorate provides science and technology support to DTRA and the Defense Department’s Chemical and Biological Defense program by managing and integrating medical and physical research projects and initiatives. The Tauri Group and its teammates will provide scientific analyses, technology assessments, program management assistance, and business operations support to the directorate. The firm’s key subcontractors are ANSER, Inc., Bull & Associates, Inc., Lovelace Respiratory Research Institute, LMI, and ManTech International [MANT]. The team will also get specialized support from Martin, Blanck & Associates, the University of Pittsburgh Medical Center and Mercury Healthcare Consulting.